Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study

Graham Mazereeuw1 Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada;2 Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada;4 CIHR Training Program in Neurodegenerative Lipidomics, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada

Nathan Herrmann1 Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada;5 Department of Psychiatry, University of Toronto, Toronto, ON, Canada

Hongbin Xu3 Ottawa Institute of Systems Biology and Neural Regeneration Laboratory, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada;4 CIHR Training Program in Neurodegenerative Lipidomics, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada

Alexandre P Blanchard3 Ottawa Institute of Systems Biology and Neural Regeneration Laboratory, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada;4 CIHR Training Program in Neurodegenerative Lipidomics, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada

Daniel Figeys3 Ottawa Institute of Systems Biology and Neural Regeneration Laboratory, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada;4 CIHR Training Program in Neurodegenerative Lipidomics, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada

Paul I Oh6 UHN Toronto Rehabilitation Institute, Toronto, ON, Canada

Steffany AL Bennett3 Ottawa Institute of Systems Biology and Neural Regeneration Laboratory, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada;4 CIHR Training Program in Neurodegenerative Lipidomics, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada

Krista L Lanctôt1 Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada;2 Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada;4 CIHR Training Program in Neurodegenerative Lipidomics, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada;5 Department of Psychiatry, University of Toronto, Toronto, ON, Canada;6 UHN Toronto Rehabilitation Institute, Toronto, ON, CanadaCorrespondence[email protected]

show all

Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study

Table 1 Patient characteristics (n=26)

Table 2 Unadjusted linear regression correlations between PAF species and depressive symptoms in CAD patients (n=26)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study

Figures & data

Table 1 Patient characteristics (n=26)

Table 2 Unadjusted linear regression correlations between PAF species and depressive symptoms in CAD patients (n=26)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date